The latest price target for Kodiak Sciences (NASDAQ:KOD) was reported by Chardan Capital on May 11, 2026. The analyst firm set a price target for $61.00 expecting KOD to rise to within 12 months (a possible 97.60% upside). 17 analyst firms have reported ratings in the last year.

The latest analyst rating for Kodiak Sciences (NASDAQ:KOD) was provided by Chardan Capital, and Kodiak Sciences upgraded their buy rating.

The last upgrade for Kodiak Sciences Inc happened on May 11, 2026 when Chardan Capital raised their price target to $61. Chardan Capital previously had a neutral for Kodiak Sciences Inc.

The last downgrade for Kodiak Sciences Inc happened on July 27, 2023 when UBS changed their price target from $15 to $4 for Kodiak Sciences Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kodiak Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kodiak Sciences was filed on May 11, 2026 so you should expect the next rating to be made available sometime around May 11, 2027.

While ratings are subjective and will change, the latest Kodiak Sciences (KOD) rating was a upgraded with a price target of $14.00 to $61.00. The current price Kodiak Sciences (KOD) is trading at is $30.87, which is within the analyst’s predicted range.